Oleanolic Acid and Ursolic Acid Induce UGT1A1 Expression in HepG2 Cells by Activating PXR Rather Than CAR

Na Yao1, Caiwen Zeng2, Tao Zhan1

  • 1Clinical Pharmacology Institute, Nanchang University, Nanchang, China.

Frontiers in Pharmacology
|October 16, 2019
PubMed

Insights

Oleanolic acid (OA) and ursolic acid (UA) significantly increase the expression of UGT1A enzymes in liver cells. This induction of UGT1A1 is primarily mediated by the pregnane X receptor (PXR) pathway.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Hepatology

Background:

  • Oleanolic acid (OA) and ursolic acid (UA) are natural compounds with known biological activities.
  • Previous studies showed OA and UA affect UGT1A enzyme activity but not their expression.
  • The regulatory mechanisms of OA and UA on UGT1A expression in HepG2 cells were unclear.

Purpose of the Study:

  • To investigate the effect of OA and UA on the expression of UDP-glucuronosyltransferases (UGT1As) in HepG2 cells.
  • To elucidate the regulatory mechanisms of OA and UA on UGT1A1 expression via pregnane X receptor (PXR) and constitutive androstane receptor (CAR) signaling pathways.

Main Methods:

  • Quantitative PCR (Q-PCR) and Western blotting to analyze gene and protein expression.
  • Dual-luciferase reporter gene assays to assess PXR and CAR activity.
  • Silencing of PXR and CAR in HepG2 cells to determine their roles in UGT1A1 regulation.

Main Results:

  • OA and UA significantly induced the expression of UGT1A1, UGT1A3, UGT1A4, and UGT1A9 in HepG2 cells.
  • Both compounds upregulated PXR expression but did not affect CAR expression.
  • OA and UA promoted PXR-mediated UGT1A1 activity, with PXR silencing abolishing the induction.
  • UGT1A1 expression was elevated in CAR-silenced cells, suggesting a PXR-dependent mechanism.

Conclusions:

  • OA and UA induce the expression of multiple UGT1A isoforms in HepG2 cells.
  • The induction of UGT1A1 by OA and UA is mediated through the activation of the PXR signaling pathway.
  • CAR signaling is not involved in the regulation of UGT1A1 expression by OA and UA.

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.2K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.1K
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.8K
Phase II Reactions: Glucuronidation01:24

Phase II Reactions: Glucuronidation

Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
1.5K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
964
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.4K